What Are the Three Dimensional Soft Tissue Changes That Occur After Orthognathic Surgery for Skeletal Class II Patients? Pre-test Post-test Quasi Experimental Study

October 3, 2018 updated by: Amira Moussa, Cairo University
the aim of the study is to establish reference data that could be used for the creation of more accurate three dimensional prediction of soft tissue outcome.

Study Overview

Status

Unknown

Detailed Description

in this study, 15 skeletal class 2 orthognathic patients will be selected. CBCT and proface will be done preoperatively. after the surgery and 6 months later the imaging investigations will be repeated to investigate the soft tissue changes that have resulted due to the bone movement.

Study Type

Observational

Enrollment (Anticipated)

15

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

patients with class 2 skeletal deformity, over 18 years and younger than 40

Description

Inclusion Criteria:

  • Patients with class II skeletal deformity
  • Patients must be over 18 years of age to allow for growth cessation
  • Patients must not have any systemic condition which contraindicates general anaesthesia

Exclusion Criteria:

  • o patients with cleft palate

    • patients with syndromes affecting their craniofacial structure
    • patients with facial scars
    • patients with severe facial asymmetry

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
3D soft-tissue changes (linear)
Time Frame: 6 months
the changes that have occurred in the soft tissue of the face after undergoing orthognathic surgery
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of soft tissue change to hard tissue change
Time Frame: 6 months
the distance that the soft tissue has moved compared to the underlying bone, as a percentage.
6 months
Is the esthetic outcome as expected/imagined?
Time Frame: 6 months
using a 100mm visual analogue scale the patient will be asked to score how the aesthetic outcome measured against his expectations. 0mm is the worst score where the changes havent met the expectations at all and 100mm is where the outcome has perfectly met the expectation.
6 months
3D soft-tissue changes (angular)
Time Frame: 6 months
the changes that have occurred in the soft tissue of the face after undergoing orthognathic surgery
6 months
3D soft-tissue changes (volumetric)
Time Frame: 6 months
the changes that have occurred in the soft tissue of the face after undergoing orthognathic surgery
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

February 1, 2019

Primary Completion (Anticipated)

August 1, 2020

Study Completion (Anticipated)

August 1, 2021

Study Registration Dates

First Submitted

September 26, 2018

First Submitted That Met QC Criteria

September 26, 2018

First Posted (Actual)

September 27, 2018

Study Record Updates

Last Update Posted (Actual)

October 4, 2018

Last Update Submitted That Met QC Criteria

October 3, 2018

Last Verified

October 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • cebd-cu-2017-04-05

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Orthognathic Surgery

Subscribe